Detumomab is a mouse monoclonal antibody targeting human B-cell lymphoma.[1][2]
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Mouse |
Target | B-lymphoma cell |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
![]() ![]() |
References
edit- ^ "International Nonproprietary Names (INN) for Pharmaceutical Substances" (PDF). WHO Drug Information. 7 (4). 1993. Archived from the original (PDF) on 14 June 2007.
- ^ Singh S, Kumar NK, Dwiwedi P, Charan J, Kaur R, Sidhu P, Chugh VK (2018). "Monoclonal Antibodies: A Review". Current Clinical Pharmacology. 13 (2): 85–99. doi:10.2174/1574884712666170809124728. PMID 28799485. S2CID 27211386.
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.